1. Gotto, AM Jr (1986) Treatment of hyperlipidemia. Am J Cardiol 57, 11G–16G.
2. Al-Daghri, NM, Al-Attas, OS & Al-Rubeaan, K (2007) The atherogenic and metabolic impact of non-HDL cholesterol versus other lipid sub-components among non-diabetic and diabetic Saudis. Lipids Health Dis 6, 9.
3. Cui, Y, Blumenthal, RS, Flaws, JA et al. (2001) Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Arch Intern Med 161, 1413–1419.
4. Frost, PH & Havel, RJ (1998) Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Am J Cardiol 81, 26B–31B.
5. Grundy, SM (2001) Non-high-density lipoprotein cholesterol level as potential risk predictor and therapy target. Arch Intern Med 161, 1379–1380.
6. Orakzai, SH, Nasir, K, Blaha, M et al. (2009) Non-HDL cholesterol is strongly associated with coronary artery calcification in asymptomatic individuals. Atherosclerosis 202, 289–295.
7. Packard, CJ & Saito, Y (2004) Non-HDL cholesterol as a measure of atherosclerotic risk. J Atheroscler Thromb 11, 6–14.
8. Chelland Campbell, S, Moffatt, RJ & Stamford, BA (2008) Smoking and smoking cessation – the relationship between cardiovascular disease and lipoprotein metabolism: a review. Atherosclerosis 201, 225–235.
9. Fransen, HP, de Jong, N, Wolfs, M et al. (2007) Customary use of plant sterol and plant stanol enriched margarine is associated with changes in serum plant sterol and stanol concentrations in humans. J Nutr 137, 1301–1306.
10. de Jong, A, Plat, J & Mensink, RP (2003) Metabolic effects of plant sterols and stanols. J Nutr Biochem 14, 362–369.
11. Marinangeli, CP, Varady, KA & Jones, PJ (2006) Plant sterols combined with exercise for the treatment of hypercholesterolemia: overview of independent and synergistic mechanisms of action. J Nutr Biochem 17, 217–224.
12. Plat, J & Mensink, RP (2005) Plant stanol and sterol esters in the control of blood cholesterol levels: mechanism and safety aspects. Am J Cardiol 96, 15D–22D.
13. Plat, J & Mensink, RP (2002) Increased intestinal ABCA1 expression contributes to the decrease in cholesterol absorption after plant stanol consumption. FASEB J 16, 1248–1253.
14. Trautwein, EA (2003) Proposed mechanisms of cholesterol-lowering action of plant sterols. Eur J Lipid Sci Technol 105, 171–185.
15. Eussen, S, Klungel, O, Garssen, J et al. (2010) Support of drug therapy using functional foods and dietary supplements: focus on statin therapy. Br J Nutr 103, 1260–1277.
16. Demonty, I, Ras, RT, van der Knaap, HC et al. (2009) Continuous dose–response relationship of the LDL-cholesterol-lowering effect of phytosterol intake. J Nutr 139, 271–284.
17. Katan, MB, Grundy, SM, Jones, P et al. (2003) Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin Proc 78, 965–978.
18. Freemantle, N & Hessel, F (2009) The applicability and generalizability of findings from clinical trials for health-policy decisions. PharmacoEconomics 27, 5–10.
19. Silverman, SL (2009) From randomized controlled trials to observational studies. Am J Med 122, 114–120.
20. Cramer, JA, Roy, A, Burrell, A et al. (2008) Medication compliance and persistence: terminology and definitions. Value Health 11, 44–47.
21. Liberopoulos, EN, Florentin, M, Mikhailidis, DP et al. (2008) Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortality. Expert Opin Drug Saf 7, 717–725.
22. Verschuren, WM, Blokstra, A, Picavet, HS et al. (2008) Cohort profile: the Doetinchem Cohort Study. Int J Epidemiol 37, 1236–1241.
23. Ocke, MC, Bueno-de-Mesquita, HB, Goddijn, HE et al. (1997) The Dutch EPIC food frequency questionnaire. I. Description of the questionnaire, and relative validity and reproducibility for food groups. Int J Epidemiol 26, Suppl. 1, S37–S48.
24. Ocke, MC, Bueno-de-Mesquita, HB, Pols, MA et al. (1997) The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. Int J Epidemiol 26, Suppl. 1, S49–S58.
25. Voorlichtingsbureau voor de Voeding (1996) Stichting NEVO Nederlands Voedingsstoffenbestand 1996. The Hague: Voorlichtingsbureau voor de Voeding.
26. Herings, RM, Bakker, A, Stricker, BH et al. (1992) Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts. J Epidemiol Community Health 46, 136–140.
27. Institute for Drug Outcome Research (2002) PHARMO Records Linkage System. http://www.pharmo.nl/ (accessed November 2009).
28. Hepburn, P, Howlett, J, Boeing, H et al. (2008) The application of post-market monitoring to novel foods. Food Chem Toxicol 46, 9–33.
30. Penning-van Beest, FJ, Termorshuizen, F, Goettsch, WG et al. (2007) Adherence to evidence-based statin guidelines reduces the risk of hospitalizations for acute myocardial infarction by 40 %: a cohort study. Eur Heart J 28, 154–159.
31. Houterman, S, Verschuren, WM, Oomen, CM et al. (2001) Trends in total and high density lipoprotein cholesterol and their determinants in The Netherlands between 1993 and 1997. Int J Epidemiol 30, 1063–1070.
32. Greenland, S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79, 340–349.
33. Ketomaki, A, Gylling, H & Miettinen, TA (2005) Non-cholesterol sterols in serum, lipoproteins, and red cells in statin-treated FH subjects off and on plant stanol and sterol ester spreads. Clin Chim Acta 353, 75–86.
34. de Jong, N, Zuur, A, Wolfs, MC et al. (2007) Exposure and effectiveness of phytosterol/-stanol-enriched margarines. Eur J Clin Nutr 61, 1407–1415.
35. Simons, LA (2002) Additive effect of plant sterol-ester margarine and cerivastatin in lowering low-density lipoprotein cholesterol in primary hypercholesterolemia. Am J Cardiol 90, 737–740.
36. Anon. (1984) The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA 251, 365–374.
37. Law, MR, Wald, NJ & Thompson, SG (1994) By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 308, 367–372.
38. Crowley, LV (2009) An Introduction to Human Disease. Pathology and Pathophysiology Correlations, 8th ed. Sudbury: Jones and Bartlett Publishers.
39. Hallikainen, MA, Sarkkinen, ES, Gylling, H et al. (2000) Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low-fat diet. Eur J Clin Nutr 54, 715–725.
40. Weststrate, JA & Meijer, GW (1998) Plant sterol-enriched margarines and reduction of plasma total- and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur J Clin Nutr 52, 334–343.
41. Noakes, M, Clifton, P, Ntanios, F et al. (2002) An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid concentrations. Am J Clin Nutr 75, 79–86.
42. O'Neill, FH, Brynes, A, Mandeno, R et al. (2004) Comparison of the effects of dietary plant sterol and stanol esters on lipid metabolism. Nutr Metab Cardiovasc Dis 14, 133–142.
43. de Jong, A, Plat, J, Ltjohann, D et al. (2008) Effects of long-term plant sterol or stanol ester consumption on lipid and lipoprotein metabolism in subjects on statin treatment. Br J Nutr 100, 937–941.
44. O'Neill, F, Sanders, TAB & Thompson, G (2005) Comparison of efficacy of plant stanol ester and sterol ester: short-term and longer-term studies. Am J Cardiol 96, 29D–36D.
45. Wolfs, M, de Jong, N, Ocke, MC et al. (2006) Effectiveness of customary use of phytosterol/-stanol enriched margarines on blood cholesterol lowering. Food Chem Toxicol 44, 1682–1688.